Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 36
Filter
1.
Evol Med Public Health ; 10(1): 71-86, 2022.
Article in English | MEDLINE | ID: mdl-35186295

ABSTRACT

BACKGROUND AND OBJECTIVES: The probiotic Escherichia coli strain Nissle 1917 (EcN) has been shown to effectively prevent and alleviate intestinal diseases. Despite the widespread medical application of EcN, we still lack basic knowledge about persistence and evolution of EcN outside the human body. Such knowledge is important also for public health aspects, as in contrast to abiotic therapeutics, probiotics are living organisms that have the potential to evolve. This study made use of experimental evolution of EcN in an insect host, the red flour beetle Tribolium castaneum, and its flour environment. METHODOLOGY: Using a serial passage approach, we orally introduced EcN to larvae of T.castaneum as a new host, and also propagated it in the flour environment. After eight propagation cycles, we analyzed phenotypic attributes of the passaged replicate EcN lines, their effects on the host in the context of immunity and infection with the entomopathogen Bacillus thuringiensis, and potential genomic changes using WGS of three of the evolved lines. RESULTS: We observed weak phenotypic differences between the ancestral EcN and both, beetle and flour passaged EcN lines, in motility and growth at 30°C, but neither any genetic changes, nor the expected increased persistence of the beetle-passaged lines. One of these lines displayed distinct morphological and physiological characteristics. CONCLUSIONS AND IMPLICATIONS: Our findings suggest that EcN remains rather stable during serial passage in an insect. Weak phenotypic changes in growth and motility combined with a lack of genetic changes indicate a certain degree of phenotypic plasticity of EcN. LAY SUMMARY: For studying adaptation of the human probiotic Escherichia coli strain Nissle 1917, we introduced it to a novel insect host system and its environment using a serial passage approach. After passage, we observed weak phenotypic changes in growth and motility but no mutations or changes in persistence inside the host.

2.
Leukemia ; 36(2): 426-437, 2022 02.
Article in English | MEDLINE | ID: mdl-34465866

ABSTRACT

Persistence of malignant clones is a major determinant of adverse outcome in patients with hematologic malignancies. Despite the fact that the majority of patients with acute myeloid leukemia (AML) achieve complete remission after chemotherapy, a large proportion of them relapse as a result of residual malignant cells. These persistent clones have a competitive advantage and can re-establish disease. Therefore, targeting strategies that specifically diminish cell competition of malignant cells while leaving normal cells unaffected are clearly warranted. Recently, our group identified YBX1 as a mediator of disease persistence in JAK2-mutated myeloproliferative neoplasms. The role of YBX1 in AML, however, remained so far elusive. Here, inactivation of YBX1 confirms its role as an essential driver of leukemia development and maintenance. We identify its ability to amplify the translation of oncogenic transcripts, including MYC, by recruitment to polysomal chains. Genetic inactivation of YBX1 disrupts this regulatory circuit and displaces oncogenic drivers from polysomes, with subsequent depletion of protein levels. As a consequence, leukemia cells show reduced proliferation and are out-competed in vitro and in vivo, while normal cells remain largely unaffected. Collectively, these data establish YBX1 as a specific dependency and therapeutic target in AML that is essential for oncogenic protein expression.


Subject(s)
Biomarkers, Tumor/metabolism , Cell Competition , Janus Kinase 2/metabolism , Leukemia, Myeloid, Acute/pathology , Mutation , Proto-Oncogene Proteins c-myc/metabolism , Y-Box-Binding Protein 1/metabolism , Animals , Apoptosis , Biomarkers, Tumor/genetics , Cell Proliferation , Humans , Janus Kinase 2/genetics , Leukemia, Myeloid, Acute/genetics , Leukemia, Myeloid, Acute/metabolism , Mice , Prognosis , Proto-Oncogene Proteins c-myc/genetics , Tumor Cells, Cultured , Xenograft Model Antitumor Assays , Y-Box-Binding Protein 1/genetics
3.
Nature ; 588(7836): 157-163, 2020 12.
Article in English | MEDLINE | ID: mdl-33239784

ABSTRACT

Janus kinases (JAKs) mediate responses to cytokines, hormones and growth factors in haematopoietic cells1,2. The JAK gene JAK2 is frequently mutated in the ageing haematopoietic system3,4 and in haematopoietic cancers5. JAK2 mutations constitutively activate downstream signalling and are drivers of myeloproliferative neoplasm (MPN). In clinical use, JAK inhibitors have mixed effects on the overall disease burden of JAK2-mutated clones6,7, prompting us to investigate the mechanism underlying disease persistence. Here, by in-depth phosphoproteome profiling, we identify proteins involved in mRNA processing as targets of mutant JAK2. We found that inactivation of YBX1, a post-translationally modified target of JAK2, sensitizes cells that persist despite treatment with JAK inhibitors to apoptosis and results in RNA mis-splicing, enrichment for retained introns and disruption of the transcriptional control of extracellular signal-regulated kinase (ERK) signalling. In combination with pharmacological JAK inhibition, YBX1 inactivation induces apoptosis in JAK2-dependent mouse and primary human cells, causing regression of the malignant clones in vivo, and inducing molecular remission. This identifies and validates a cell-intrinsic mechanism whereby differential protein phosphorylation causes splicing-dependent alterations of JAK2-ERK signalling and the maintenance of JAK2V617F malignant clones. Therapeutic targeting of YBX1-dependent ERK signalling in combination with JAK2 inhibition could thus eradicate cells harbouring mutations in JAK2.


Subject(s)
Janus Kinase 2/genetics , Janus Kinase 2/metabolism , Neoplasms/genetics , Neoplasms/pathology , Y-Box-Binding Protein 1/metabolism , Animals , Apoptosis/drug effects , Cell Line , Cells, Cultured , Clone Cells/metabolism , Clone Cells/pathology , Female , Heterografts , Humans , Intracellular Signaling Peptides and Proteins/genetics , Intracellular Signaling Peptides and Proteins/metabolism , Introns/genetics , Janus Kinase 2/antagonists & inhibitors , MAP Kinase Signaling System/drug effects , Male , Mice , Mutation , Neoplasm Transplantation , Neoplasms/drug therapy , Phosphoproteins/analysis , Phosphorylation , Protein Serine-Threonine Kinases/genetics , Protein Serine-Threonine Kinases/metabolism , Proteome/analysis , Proteomics , RNA Splicing/genetics , Remission Induction , Y-Box-Binding Protein 1/antagonists & inhibitors , Y-Box-Binding Protein 1/chemistry
4.
Dev Comp Immunol ; 106: 103606, 2020 05.
Article in English | MEDLINE | ID: mdl-31904432

ABSTRACT

Although the ticks Amblyomma sculptum and Amblyomma aureolatum are important vectors of Rickettsia rickettsii, causative agent of the life-threatening Rocky Mountain spotted fever, A. aureolatum is considerably more susceptible to infection than A. sculptum. As the microbiota can interfere with the colonization of arthropod midgut (MG) by pathogens, in the current study we analyzed the MG microbiota of both tick species. Our results revealed that the MG of A. aureolatum harbors a prominent microbiota, while A. sculptum does not. Remarkably, a significant reduction of the bacterial load was recorded in R. rickettsii-infected A. aureolatum. In addition, the taxonomy analysis of the MG bacterial community of A. aureolatum revealed a dominance of the genus Francisella, suggesting an endosymbiosis. This study is the first step in getting insights into the mechanisms underlying the interactions among Amblyomma species, their microbiota and R. rickettsii. Additional studies to better understand these mechanisms are required and may help the development of novel alternatives to block rickettsial transmission.


Subject(s)
Amblyomma/microbiology , Arachnid Vectors/microbiology , Francisella/physiology , Gastrointestinal Tract/microbiology , Microbiota/physiology , Rickettsia rickettsii/physiology , Rocky Mountain Spotted Fever/transmission , Animals , Disease Susceptibility , Disease Vectors , Host-Pathogen Interactions , Humans , Symbiosis
5.
J Allergy Clin Immunol ; 144(4S): S19-S30, 2019 10.
Article in English | MEDLINE | ID: mdl-31369803

ABSTRACT

Mast cells (MCs) are capable of executing powerful inflammatory response programs triggered by surface IgE cross-linking or through pattern recognition receptors. The question of how MCs contribute to human disease has been intensely investigated and stimulated much controversy. Correlative evidence comes from human studies, pointing to pathogenetic or protective MC functions in patients with atopic conditions, autoimmune disorders, type 2 diabetes, chronic urticaria, mastocytosis, and cancer. Experiments in MC-deficient mice underpinned key roles for MCs in patients with IgE-mediated allergic conditions. Important pathogenetic MC contributions to other inflammatory and neoplastic conditions were suggested by studies in traditional KIT mutant MC-deficient mouse strains. However, many of these findings were not reproduced in more recently developed improved mouse models of MC deficiency, largely ruling out roles for MCs in mouse models for autoimmune disease, diabetes, and cancer. We discuss limitations of studies in mice and human subjects and provide suggestions for how they can be overcome, such as through the development of specific and selective MC-targeted treatments.


Subject(s)
Immunoglobulin E/immunology , Infections/immunology , Inflammation/immunology , Mast Cells/immunology , Neoplasms/immunology , Wounds and Injuries/immunology , Animals , Chymases/immunology , Female , Humans , Infections/pathology , Inflammation/pathology , Lymphocyte Activation , Mast Cells/pathology , Neoplasms/pathology , Pregnancy , Receptors, IgE/immunology , Th2 Cells/immunology , Th2 Cells/pathology , Toll-Like Receptor 2/immunology , Tumor Microenvironment/immunology , Wounds and Injuries/pathology
6.
mSphere ; 3(3)2018 Jun 27.
Article in English | MEDLINE | ID: mdl-29925673

ABSTRACT

One might expect yeasts in soil to be highly dispersed via water or insects, forming ephemeral, genetically heterogeneous populations subject to competition and environmental stochasticity. Here, we report persistence of genotypes of the yeast Saccharomyces paradoxus in space and time. Within 1 km2 in a mixed hardwood forest on scales from centimeters to tens of meters, we detected persistence over 3 years of native genotypes, identified by single nucleotide polymorphisms (SNPs) genome-wide, of the wild yeast Saccharomyces paradoxus growing around Quercus rubra and Quercus alba Yeasts were recovered by enrichment in ethanol-containing medium, which measures only presence or absence, not abundance. Additional transplantation experiments employed strains marked with spontaneous defects in the URA3 gene, which also confer resistance to 5-fluoroorotic acid (5FOA). Plating soil suspensions from transplant sites on 5FOA-containing medium permitted one-step quantification of yeast CFU, with no interference from other unmarked yeasts or microorganisms. After an initial steep decrease in abundance, the yeast densities fluctuated over time, increasing in association with rainfall and decreasing in association with drought. After 18 months, the transplanted yeasts remained in place on the nine sites. In vitro transplantation experiments into nonsterile soil in petri dishes showed similar patterns of persistence and response to moisture and drought. To determine whether Saccharomyces cerevisiae, not previously recovered from soils regionally, can persist in our cold climate sites, we transplanted marked S. cerevisiae alone and in mixture with S. paradoxus in the fall of 2017. Five months later, S. cerevisiae persisted to the same extent as S. paradoxusIMPORTANCESaccharomyces yeasts are intensively studied in biological research and in their domesticated roles in brewing and baking, and yet, remarkably little is known about their mode of life in forest soils. We report here that resident genotypes of the yeast S. paradoxus are persistent on a time scale of years in their microhabitats in forest soils. We also show that resident genotypes can be replaced by transplanted yeast genotypes. The high inoculum levels in experimental transplantations rapidly decreased over time, but the transplanted genotypes persisted at low abundance. We conclude that, in forest soils, Saccharomyces yeasts exist at very low abundance and that dispersal events are rare.


Subject(s)
Forests , Genotype , Saccharomyces cerevisiae/classification , Saccharomyces cerevisiae/isolation & purification , Colony Count, Microbial , Genome, Fungal , Polymorphism, Single Nucleotide , Quercus/growth & development , Saccharomyces cerevisiae/genetics , Soil Microbiology , Spatio-Temporal Analysis
7.
Proc Natl Acad Sci U S A ; 113(9): E1266-75, 2016 Mar 01.
Article in English | MEDLINE | ID: mdl-26884207

ABSTRACT

Cluster of differentiation 1c (CD1c)-dependent self-reactive T cells are abundant in human blood, but self-antigens presented by CD1c to the T-cell receptors of these cells are poorly understood. Here we present a crystal structure of CD1c determined at 2.4 Å revealing an extended ligand binding potential of the antigen groove and a substantially different conformation compared with known CD1c structures. Computational simulations exploring different occupancy states of the groove reenacted these different CD1c conformations and suggested cholesteryl esters (CE) and acylated steryl glycosides (ASG) as new ligand classes for CD1c. Confirming this, we show that binding of CE and ASG to CD1c enables the binding of human CD1c self-reactive T-cell receptors. Hence, human CD1c adopts different conformations dependent on ligand occupancy of its groove, with CE and ASG stabilizing CD1c conformations that provide a footprint for binding of CD1c self-reactive T-cell receptors.


Subject(s)
Antigens, CD1/immunology , Cholesterol Esters/metabolism , Glycoproteins/immunology , T-Lymphocytes/immunology , Antigens, CD1/chemistry , Antigens, CD1d , Glycoproteins/chemistry , Humans , Molecular Dynamics Simulation , Protein Conformation
9.
Neuromuscul Disord ; 23(1): 66-74, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23102899

ABSTRACT

Pipestem-capillaries in necrotizing myopathy, have been reported as a feature of a distinct type of myopathy. Here, we analyze four muscle biopsy specimens from patients exhibiting endomysial fibrosis associated with pipestem capillaries using histological and electronmicroscopic techniques. However, only one case displayed all of the originally described features, including necrotic fibres, capillary thickening and lack of a significant lymphocytic inflammation, while one case exhibited striking capillary pathology with minimal necrosis and absence of inflammation, and the other two cases were accompanied by additional pathological features. These data support the existence of a microangiopathy with pipestem capillaries as a characteristic and distinct histopathological pattern, and indicate that it occurs in the context of a variety of muscular disorders broader than initially suspected. Furthermore, we show that the pipestem-capillary associated decrease in fibre size is at least in part a result of hypoxic changes.


Subject(s)
Capillaries/pathology , Muscle, Skeletal/blood supply , Muscle, Skeletal/pathology , Muscular Diseases/pathology , Adult , Aged , Aged, 80 and over , Biopsy , Complement Membrane Attack Complex/metabolism , Creatine Kinase/metabolism , Female , Humans , Hypoxia-Inducible Factor 1, alpha Subunit/metabolism , Male , Middle Aged , Muscle, Skeletal/metabolism , Necrosis
10.
PLoS One ; 6(6): e20784, 2011.
Article in English | MEDLINE | ID: mdl-21695198

ABSTRACT

Chlamydia pneumoniae (CP) is associated with induction and exacerbation of asthma. CP infection can induce allergic airway sensitization in mice in a dose- and time-dependent manner. Allergen exposure 5 days after a low dose (mild-moderate), but not a high dose (severe) CP infection induces antigen sensitization in mice. Innate immune signals play a critical role in controlling CP infection induced allergic airway sensitization, however these mechanisms have not been fully elucidated. Wild-type, TLR2-/-, and TLR4-/- mice were infected intranasally (i.n.) with a low dose of CP, followed by i.n. exposure to human serum albumin (HSA) and challenged with HSA 2 weeks later. Airway inflammation, immunoglobulins, eosinophils, and goblet cells were measured. Low dose CP infection induced allergic sensitization in TLR2-/- mice, but not in TLR4-/- mice, due to differential Treg responses in these genotypes. TLR2-/- mice had reduced numbers of Tregs in the lung during CP infection while TLR4-/- mice had increased numbers. High dose CP infection resulted in an increase in Tregs and pDCs in lungs, which prevented antigen sensitization in WT mice. Depletion of Tregs or pDCs resulted in allergic airway sensitization. We conclude that Tregs and pDCs are critical determinants regulating CP infection-induced allergic sensitization. Furthermore, TLR2 and TLR4 signaling during CP infection may play a regulatory role through the modulation of Tregs.


Subject(s)
Chlamydophila pneumoniae/immunology , Dendritic Cells/immunology , Immunization , Pneumonia, Bacterial/immunology , Pneumonia, Bacterial/microbiology , Respiratory Hypersensitivity/immunology , T-Lymphocytes, Regulatory/immunology , Animals , Antigens, Bacterial/immunology , Bordetella/immunology , Bordetella/radiation effects , Chlamydophila pneumoniae/radiation effects , Eosinophils/pathology , Humans , Inflammation/complications , Inflammation/microbiology , Inflammation/pathology , Lung/immunology , Lung/microbiology , Lung/pathology , Lymphocyte Depletion , Mice , Microbial Viability/radiation effects , Pneumonia, Bacterial/complications , Pneumonia, Bacterial/pathology , Respiratory Hypersensitivity/complications , Respiratory Hypersensitivity/microbiology , Respiratory Hypersensitivity/pathology , Serum Albumin/immunology , Signal Transduction/immunology , Signal Transduction/radiation effects , Time Factors , Toll-Like Receptor 2/deficiency , Toll-Like Receptor 2/metabolism , Toll-Like Receptor 4/deficiency , Toll-Like Receptor 4/metabolism , Ultraviolet Rays
11.
FEMS Immunol Med Microbiol ; 63(1): 140-3, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21635569

ABSTRACT

Lyme disease (LD) is the most common tick-borne disease in the Northern hemisphere. It is caused by Borrelia burgdorferi sensu lato, in particular, B. burgdorferi sensu stricto, Borrelia garinii, and Borrelia afzelii. However, other genospecies have been implicated as causative factors of LD as well. Borrelia burgdorferi exhibits numerous immunogenic lipoproteins, but due to strong heterogeneity, the use of these proteins for serodiagnosis and vaccination is hampered. We and others have identified acylated cholesteryl galactosides (ACGal) as a novel glycolipid present in B. burgdorferi sensu stricto, B. afzelii, and B. garinii. ACGal is a strong antigen and the majority of patients display anti-ACGal antibodies in the chronic stages of LD. However, it is unknown whether ACGal is present in other presumably pathogenic B. burgdorferi genospecies. Therefore, we performed an analysis of the total lipid extracts of a wide spectrum of genospecies of B. burgdorferi sensu lato using thin-layer chromatography as well as Western blot and dot-blot assays. We show that ACGal is present in substantial quantities in all B. burgdorferi genospecies tested. Therefore, this molecule might improve the serological detection of rarely pathogenic genospecies, and may be used as a protective vaccine regardless of the prevailing genospecies.


Subject(s)
Antigens, Bacterial/analysis , Borrelia burgdorferi Group/chemistry , Cholesterol Esters/analysis , Galactosides/analysis , Glycolipids/analysis , Acylation , Blotting, Western , Chromatography, Thin Layer , Humans
12.
J Neurooncol ; 102(1): 163-6, 2011 Mar.
Article in English | MEDLINE | ID: mdl-20602148

ABSTRACT

Primary CNS lymphoma (PCNSL) and its variant primary intraocular lymphoma (PIOL) are rare forms of extranodal non-Hodgkin's lymphoma confined to the CNS including the retina and the optical nerve; histologically, most cases are diffuse large B cell lymphomas. PCNSL in immunocompetent patients display typical radiological features on MRI, i.e. intensely and homogeneously enhancing lesions with moderate edema. Here, we report a 52-year-old male with a history of a PIOL and two consecutive intracerebral relapses who presented with dysarthria, dysphagia, and gait ataxia. Gadolinium-enhanced T1 scans were unremarkable but multiple lesions with restricted water diffusivity were seen on diffusion-weighted imaging. Relapse of his PCNSL was secured histologically only on autopsy. The possible etiology of the diffusion-restricted lesions is discussed.


Subject(s)
Brain Neoplasms/pathology , Diffusion Magnetic Resonance Imaging , Eye Neoplasms/pathology , Lymphoma, Large B-Cell, Diffuse/pathology , Neoplasm Recurrence, Local/pathology , Brain Neoplasms/complications , Brain Neoplasms/therapy , Combined Modality Therapy , Eye Neoplasms/complications , Eye Neoplasms/therapy , Fatal Outcome , Humans , Lymphoma, Large B-Cell, Diffuse/complications , Lymphoma, Large B-Cell, Diffuse/therapy , Male , Middle Aged , Neoplasm Recurrence, Local/complications , Neoplasm Recurrence, Local/therapy
13.
Chemistry ; 16(11): 3536-44, 2010 Mar 15.
Article in English | MEDLINE | ID: mdl-20143357

ABSTRACT

Lyme disease (LD) is the most common tick-borne disease in Europe, North America, and Asia. The etiologic agents of LD are spirochetes of the group Borrelia burgdorferi sensu lato, which possess a lipid content of 25-30% of the dry weight. The major glycolipid cholesteryl 6-O-acyl-beta-D-galactopyranoside (ACGal), present in B. burgdorferi sensu stricto, B. afzelii, and B. garinii, is a specific and highly prevalent antigen frequently recognized by antibodies in late-stage LD. Here we report a convenient route for the chemical synthesis of ACGal by employing a combination of chemical synthesis steps with enzymatic transformations. This synthesized molecule was compared with bacterial extracts by immunoblots with patient sera, confirming the preserved antigenicity. Next, a glycolipid library derived from the native molecules with variations in the fatty acyl moiety and derivatives in which the cholesterol has been replaced was designed and synthesized. The chemical structures were confirmed by 1D and 2D NMR spectroscopy and mass spectrometry. The native and synthetic glycolipids were utilized in immunoblots to determine the epitope recognized by antibodies in patient sera. By this method we could demonstrate that galactose, cholesterol, and a fatty acid with a minimal chain length of four carbon atoms comprises the essential structure for recognition by antibodies. Finally, this finding allowed the synthesis of a functionalized ACGal with an omega-mercapto group at the fatty acid and a facile protection and deprotection strategy. This antigenic hapten can be conjugated to a carrier protein to effect immunization against Lyme disease.


Subject(s)
Antigens, Bacterial/chemistry , Glycolipids/chemical synthesis , Glycolipids/immunology , Lyme Disease Vaccines/immunology , Lyme Disease/immunology , Antibodies, Bacterial/blood , Antibodies, Bacterial/metabolism , Antigens, Bacterial/immunology , Antigens, Bacterial/metabolism , Borrelia burgdorferi/chemistry , Cholesterol/analogs & derivatives , Cholesterol/biosynthesis , Cholesterol/chemical synthesis , Cholesterol/chemistry , Epitopes/immunology , Epitopes/metabolism , Glycolipids/biosynthesis , Humans , Lyme Disease/prevention & control , Stereoisomerism
14.
J Biol Chem ; 284(20): 13326-13334, 2009 May 15.
Article in English | MEDLINE | ID: mdl-19307181

ABSTRACT

Borrelia burgdorferi sensu lato is the causative agent of Lyme disease (LD), an infectious disease occurring in North America, Europe, and Asia in different clinical stages. B. burgdorferi sensu lato encompasses at least 12 species, with B. burgdorferi sensu stricto, B. garinii, and B. afzelii being of highest clinical importance. Immunologic testing for LD as well as recent vaccination strategies exclusively refer to proteinaceous antigens. However, B. burgdorferi sensu stricto exhibits glycolipid antigens, including 6-O-acylated cholesteryl beta-D-galactopyranoside (ACGal), and first the data indicated that this compound may act as an immunogen. Here we investigated whether B. garinii and B. afzelii also possess this antigen, and whether antibodies directed against these compounds are abundant among patients suffering from different stages of LD. Gas-liquid chromatography/mass spectroscopy and NMR spectroscopy showed that both B. garinii and B. afzelii exhibit ACGal in high quantities. In contrast, B. hermsii causing relapsing fever features 6-O-acylated cholesteryl beta-D-glucopyranoside (ACGlc). Sera derived from patients diagnosed for LD contained antibodies against ACGal, with 80% of patients suffering from late stage disease exhibiting this feature. Antibodies reacted with ACGal from all three B. burgdorferi species tested, but not with ACGlc from B. hermsii. These data show that ACGal is present in all clinically important B. burgdorferi species, and that specific antibodies against this compound are frequently found during LD. ACGal may thus be an interesting tool for improving diagnostics as well as for novel vaccination strategies.


Subject(s)
Antibodies, Bacterial/immunology , Borrelia burgdorferi/immunology , Glycolipids/immunology , Lyme Disease Vaccines/immunology , Lyme Disease/immunology , Antibodies, Bacterial/blood , Humans , Lyme Disease/blood , Lyme Disease/diagnosis , Lyme Disease/prevention & control , Species Specificity
15.
Curr Opin Allergy Clin Immunol ; 9(1): 38-43, 2009 Feb.
Article in English | MEDLINE | ID: mdl-19106699

ABSTRACT

PURPOSE OF REVIEW: The increase in prevalence of allergic diseases, in particular of asthma, poses great difficulties to healthcare institutions in industrialized countries. According to the hygiene hypothesis, a linkage exists between exposure towards microbes in early childhood and the development of allergies; however, the original view that stimulation of the host's immune system by microbes exclusively protects against the development of allergies and asthma has been challenged by recent studies, which are summarized in this review. RECENT FINDINGS: Recent studies in mice revealed that infection with a series of microbes in the context of allergen exposure enhances antigen sensitization. Furthermore, in studies using purified toll-like receptor ligands and live bacteria, innate immune activation via MyD88 has been shown to be a causative factor in sensitization. The view that innate immune activation, under circumstances yet to be elucidated, may be a causative factor for the development of allergies is backed by epidemiologic data showing a protective effect of genetic variants, which impair toll-like receptor signaling. CONCLUSION: Recent studies in mice suggest that innate immune stimulation via microbes or their compounds, in a dose and time-dependent manner, can cause allergen sensitization, and this notion has lately been supported by epidemiologic data.


Subject(s)
Asthma/immunology , Asthma/microbiology , Immunity, Innate , Allergens/immunology , Animals , Dendritic Cells/immunology , Disease Models, Animal , Humans , Mice , Respiratory Tract Infections/immunology , Respiratory Tract Infections/microbiology , Toll-Like Receptors/immunology
16.
J Immunol ; 181(10): 7176-85, 2008 Nov 15.
Article in English | MEDLINE | ID: mdl-18981139

ABSTRACT

Experimental and clinical studies link Chlamydia pneumoniae infection to atherogenesis and atherothrombotic events, but the underlying mechanisms are unclear. We tested the hypothesis that C. pneumoniae-induced acceleration of atherosclerosis in apolipoprotein E (ApoE)(-/-) mice is reciprocally modulated by activation of TLR-mediated innate immune and liver X receptor alpha (LXRalpha) signaling pathways. We infected ApoE(-/-) mice and ApoE(-/-) mice that also lacked TLR2, TLR4, MyD88, or LXRalpha intranasally with C. pneumoniae followed by feeding of a high fat diet for 4 mo. Mock-infected littermates served as controls. Atherosclerosis was assessed in aortic sinuses and in en face preparation of whole aorta. The numbers of activated dendritic cells (DCs) within plaques and the serum levels of cholesterol and proinflammatory cytokines were also measured. C. pneumoniae infection markedly accelerated atherosclerosis in ApoE-deficient mice that was associated with increased numbers of activated DCs in aortic sinus plaques and higher circulating levels of MCP-1, IL-12p40, IL-6, and TNF-alpha. In contrast, C. pneumoniae infection had only a minimal effect on atherosclerosis, accumulation of activated DCs in the sinus plaques, or circulating cytokine increases in ApoE(-/-) mice that were also deficient in TLR2, TLR4, or MyD88. However, C. pneumoniae-induced acceleration of atherosclerosis in ApoE(-/-) mice was further enhanced in ApoE(-/-)LXRalpha(-/-) double knockout mice and was accompanied by higher serum levels of IL-6 and TNF-alpha. We conclude that C. pneumoniae infection accelerates atherosclerosis in hypercholesterolemic mice predominantly through a TLR/MyD88-dependent mechanism and that LXRalpha appears to reciprocally modulate and reduce the proatherogenic effects of C. pneumoniae infection.


Subject(s)
Atherosclerosis/microbiology , Chlamydia Infections/complications , DNA-Binding Proteins/metabolism , Myeloid Differentiation Factor 88/metabolism , Receptors, Cytoplasmic and Nuclear/metabolism , Signal Transduction/physiology , Toll-Like Receptors/metabolism , Animals , Aorta/immunology , Aorta/pathology , Apolipoproteins E/deficiency , Apolipoproteins E/genetics , Atherosclerosis/metabolism , Chlamydia Infections/metabolism , Chlamydophila pneumoniae , Cytokines/blood , Cytokines/immunology , DNA-Binding Proteins/genetics , Dendritic Cells/immunology , Dendritic Cells/metabolism , Fluorescent Antibody Technique , Gene Expression , Granulocyte-Macrophage Colony-Stimulating Factor/biosynthesis , Granulocyte-Macrophage Colony-Stimulating Factor/genetics , Hypercholesterolemia/complications , Immunohistochemistry , Liver X Receptors , Mice , Mice, Knockout , Myeloid Differentiation Factor 88/genetics , Oligonucleotide Array Sequence Analysis , Orphan Nuclear Receptors , Receptors, Cytoplasmic and Nuclear/genetics , Reverse Transcriptase Polymerase Chain Reaction , Toll-Like Receptors/genetics
17.
J Allergy Clin Immunol ; 122(3): 595-602.e5, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18774395

ABSTRACT

BACKGROUND: The original hygiene hypothesis predicts that infections should protect against asthma but does not account for increasing evidence that certain infections might also promote asthma development. A mechanistic reconciliation of these findings has not yet emerged. In particular, the role of innate immunity in this context is unclear. OBJECTIVE: We sought to test whether bacterial respiratory tract infection causes airway sensitization toward an antigen encountered in parallel and to elucidate the contribution of innate immune responses. METHODS: Mice were infected with different doses of Chlamydia pneumoniae, followed by exposure to human serum albumin (HSA) and challenge with HSA 2 weeks later. Airway inflammation, immunoglobulins, and lymph node cytokines were assessed. Furthermore, adoptive transfer of dendritic cells (DCs) and depletion of regulatory T (Treg) cells was performed. RESULTS: C pneumoniae-induced lung inflammation triggered sensitization toward HSA, resulting in eosinophilic airway inflammation after HSA challenge. Airway sensitization depended on the severity and timing of infection: low-dose infection and antigen exposure within 5 days of infection induced allergic sensitization, whereas high-dose infection or antigen exposure 10 days after infection did not. Temporal and dose-related effects reflected DC activation and could be reproduced by means of adoptive transfer of HSA-pulsed lung DCs from infected mice. MyD88 deficiency in DCs abolished antigen sensitization, and depletion of Treg cells prolonged the time window in which sensitization could occur. CONCLUSIONS: We conclude that moderate, but not severe, pulmonary bacterial infection can induce allergic sensitization to inert inhaled antigens through a mechanism that requires MyD88-dependent DC activation and is controlled by Treg cells.


Subject(s)
Chlamydophila Infections/immunology , Dendritic Cells/immunology , Immunity, Innate , Lung/immunology , Respiratory Hypersensitivity/immunology , Respiratory Tract Infections/immunology , T-Lymphocytes, Regulatory/immunology , Animals , Chlamydophila pneumoniae/immunology , Dendritic Cells/metabolism , Eosinophils/immunology , Eosinophils/metabolism , Humans , Immunoglobulin E/blood , Inflammation/complications , Inflammation/immunology , Lung/pathology , Mice , Mice, Inbred C57BL , Mice, Knockout , Myeloid Differentiation Factor 88/deficiency , Myeloid Differentiation Factor 88/metabolism , Respiratory Hypersensitivity/complications , Respiratory Tract Infections/complications , Respiratory Tract Infections/microbiology , Serum Albumin/immunology , T-Lymphocytes, Regulatory/metabolism
18.
Immunobiology ; 213(3-4): 329-40, 2008.
Article in English | MEDLINE | ID: mdl-18406378

ABSTRACT

The class of Spirochetes comprises a wide array of clinically important pathogens, including Treponema pallidum causing syphilis as well as Borrelia burgdorferi, the agent of Lyme disease (LD). Diseases caused by spirochetes are characterized by specific sequelae of host reactions, and also by characteristic antibody response patterns. Over the last decades, research on the interaction of spirochetes with the host's immune system had a strong emphasis on outer membrane lipoproteins. In fact, these structures have been convincingly shown to activate immune cells via CD14 and Toll-like receptor (TLR)-2, and recent data also indicate an interaction with lipopolysaccharide (LPS)-binding protein (LBP). In particular, the interaction of B. burgdorferi with TLR-2 could not only be demonstrated in mice, but was also supported by data showing that genetic variants of TLR-2 in humans influenced the clinical course of LD. However, there is increasing evidence that next to lipoproteins, glycolipids may also play an important role in responses of the immune system towards spirochetes. Diacylglycerol-containing glycolipids exhibiting similarities with lipoteichoic acid (LTA) of Gram-positive bacteria have been demonstrated in various Treponema species, whereas LPS-like glycolipids have been shown to be present in Leptospira. Treponema glycolipids, comparably to lipoproteins and LTA, interact with LBP, CD14 and TLRs. In contrast, complex glycolipids of high molecular weight could not be demonstrated in Borrelia, whereas these bacteria exhibit a number of unique low molecular weight glycolipids. Some of these glycolipids cause strong immediate immune responses, while others appear to be potent antigens for induction of an adaptive immune response. This review summarizes data obtained so far on amphiphilic and hydrophobic molecules from spirochetes regarding structure and influence on innate as well as adaptive immune responses.


Subject(s)
Glycolipids/metabolism , Immune System , Immunity, Innate , Lipoproteins/metabolism , Lyme Disease/microbiology , Acute-Phase Proteins/metabolism , Animals , Borrelia burgdorferi/metabolism , Carrier Proteins/metabolism , Diglycerides/metabolism , Dose-Response Relationship, Drug , Humans , Killer Cells, Natural/immunology , Leptospira/metabolism , Membrane Glycoproteins/metabolism , Models, Biological , Treponema/metabolism
19.
J Endotoxin Res ; 13(5): 305-12, 2007.
Article in English | MEDLINE | ID: mdl-17986489

ABSTRACT

Infectious diseases have a major impact on both the development and the severity of asthma. The rise in incidence of asthma in industrialized countries over the last decades has been attributed to increased hygiene standards as well as the concomitant usage of antibiotics, which together lower the incidence of infections. Although this point of view is supported by both clinical studies and experimental approaches in mice, an increasing body of evidence suggests that certain infectious diseases may predispose for the development of asthma, thus challenging the ;hygiene hypothesis' in its classical form. Toll-like receptors (TLRs) are centrally involved in orchestrating immune responses towards various micro-organisms. Because of this, it is tempting to speculate that signaling through TLRs may be involved in mechanisms provoking Th1- or Th2-biased immune responses and may, therefore, be an important factor in either preventing or promoting allergic airway disease. This review summarizes clinical and experimental data from mouse models focused on the impact of TLR-signaling on allergic asthma.


Subject(s)
Asthma/immunology , Immunity, Innate/immunology , Signal Transduction/immunology , Toll-Like Receptors/immunology , Animals , Asthma/drug therapy , Asthma/microbiology , Disease Models, Animal , Humans , Ligands , Mice , Signal Transduction/genetics , Toll-Like Receptors/genetics , Vaccines/therapeutic use
20.
Exp Mol Pathol ; 83(1): 93-103, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17335804

ABSTRACT

Emerging evidence implicating the participation of dendritic cells (DCs) and T cells in various vascular inflammatory diseases such as giant cell arteritis, Takayasu's arteritis, and atherosclerosis led us to hypothesize that they might also participate in the pathogenesis of coronary arteritis in Kawasaki disease (KD). Coronary artery specimens from 4 patients with KD and 6 control patients were obtained. Immunohistochemical and computer-assisted histomorphometric analyses were performed to detect all myeloid DCs (S-100(+), fascin(+)), all plasmacytoid DCs (CD123(+)) as well as specific DC subsets (mature myeloid DCs [CD83(+)], myeloid [BDCA-1(+)] and plasmacytoid DC precursors [BDCA-2(+)]), T cells (CD3(+)), and all antigen-presenting cells (HLA-DR(+)). Co-localization of DCs with T cells was assessed using double immunostaining. Significantly more myeloid DCs at a precursor, immature or mature stage were found in coronary lesions of KD patients than in controls. Myeloid DC precursors were distributed equally in the intima and adventitia. Mature myeloid DCs were particularly abundant in the adventitia. There was a significant correlation between mature DCs and HLA-DR expression. Double immunostaining demonstrated frequent contacts between myeloid DCs and T cells in the outer media and adventitia. Plasmacytoid DC precursors were rarely found in the adventitia. In conclusion, coronary artery lesions of KD patients contain increased numbers of mature myeloid DCs with high HLA-DR expression and frequent T cell contacts detected immunohistochemically. This suggests that mature arterial myeloid DCs might be activating T cells in situ and may be a significant factor in the pathogenesis of coronary arteritis in KD.


Subject(s)
CD3 Complex/metabolism , Coronary Artery Disease/metabolism , Dendritic Cells/metabolism , Mucocutaneous Lymph Node Syndrome/metabolism , Myeloid Cells/metabolism , T-Lymphocytes/metabolism , Aneurysm/pathology , Cell Differentiation , Child , Child, Preschool , Coronary Artery Disease/pathology , Dendritic Cells/cytology , Female , HLA-DR Antigens/metabolism , Humans , Immunohistochemistry , Infant , Male , Mucocutaneous Lymph Node Syndrome/pathology , Myeloid Cells/cytology , T-Lymphocytes/cytology
SELECTION OF CITATIONS
SEARCH DETAIL
...